World Canada scraps COVID-19 advisory to avoid unnecessary foreign travel
US to reopen land borders in November for fully vaccinated
WASHINGTON (AP) — The U.S. will reopen its land borders to nonessential travel next month, ending a 19-month freeze due to the COVID-19 pandemic as the country moves to require all international visitors to be vaccinated against the coronavirus. Vehicle, rail and ferry travel between the U.S. and Canada and Mexico has been largely restricted to essential travel, such as trade, since the earliest days of the pandemic. The new rules, to be announced Wednesday, will allow fully vaccinated foreign nationals to enter the U.S. regardless of the reason for travel starting in early November, when a similar easing of restrictions is set to kick in for air travel into the country.
OTTAWA (Reuters) - Canada has scrapped an official advisory urging its citizens to shun non-essential foreign travel, dropping a warning that was issued in March 2020 when the COVID-19 pandemic erupted.
The Canadian government, however, is still telling people to avoid cruise ship travel outside of the country.
In an update to its travel advisory page posted late on Thursday, Ottawa removed the advice to avoid unnecessary travel and reverted to its usual practice of issuing notices for individual countries.
"Community transmission of COVID-19 continues in many countries. You should be fully vaccinated by completing a COVID-19 vaccine series in Canada or abroad at least 14 days before traveling," it said.
The federal health ministry did not immediately respond to a request for comment.
According to official data, just under 82% of eligible Canadians had been fully vaccinated against COVID-19 by Oct 8. Federal officials are due to brief media on the fight against the pandemic at 11 a.m. EDT (1500 GMT).
(Reporting by David Ljunggren; Editing by Paul Simao)
FDA panel recommends Pfizer vaccine for kids 5-11; maker of COVAXIN looks to start US trials of vaccine: COVID-19 updates .
Children are one step closer to being able to receive a COVID-19 vaccine. Ocugen plans to begin US trials of COVAXIN in US. Latest updates.The resounding support is a major step forward for making school-age children eligible for inoculation — likely by next week — but there are still three crucial hurdles to clear: The FDA will have to sign off, an independent CDC advisory panel will review the data, and then the CDC director would have to give her clearance.